The Neuroprotective Effect of Platelet-rich Plasma on Erectile Function in Bilateral Cavernous Nerve Injury Rat Model

Chien Chih Wu, Yi No Wu, Hsiu O. Ho, Kuo Chiang Chen, Ming Thau Sheu, Han-Sun Chiang

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Introduction. Neurogenic erectile dysfunction resulting from cavernous nerve (CN) injury is a major complication caused by radical prostatectomy. The use of platelet-rich plasma (PRP) on the nerve-injured site has shown promising results for the nerve regeneration. However, the effects of PRP injection in corpus cavernosum after bilateral CN injury have never been investigated. Aim. To assess the neuroprotective effect of PRP injection in corpus cavernosum after bilateral CN injury. Methods. Male Sprague-Dawley rats were randomly divided into three groups: Group I underwent sham operation, while the remaining two groups underwent bilateral CN crush. Crush injury groups were treated at the time of injury with an application of PRP or normal saline only injection in the corpus cavernosum, respectively. Four weeks later, erectile function (EF) was assessed by CN electrosimulation, and CNs as well as penile tissue were collected for histology. Main Outcome Measures. Intracavernous pressure (ICP) monitored during electrical stimulation of CNs; myelinated axons number of CNs and dorsal penile nerve; collagen type change, number of apoptotic cells, and mRNA expression of caspase-3 and transforming growth factor-β1 (TGF-β1) in the corpus cavernosum. Results. Four weeks after surgery, in the vehicle-only group, the functional evaluation showed a lower mean maximal ICP than that in the sham group (P

Original languageEnglish
Pages (from-to)2838-2848
Number of pages11
JournalJournal of Sexual Medicine
Volume9
Issue number11
DOIs
Publication statusPublished - Nov 2012

Fingerprint

Platelet-Rich Plasma
Neuroprotective Agents
Wounds and Injuries
Injections
Nerve Crush
Pudendal Nerve
Pressure
Nerve Regeneration
Transforming Growth Factors
Erectile Dysfunction
Prostatectomy
Caspase 3
Electric Stimulation
Sprague Dawley Rats
Axons
Histology
Collagen
Cell Count
Outcome Assessment (Health Care)
Messenger RNA

Keywords

  • Cavernous nerve
  • Growth factor
  • Neurogenic erectile dysfunction
  • Neuroprotective
  • Platelet-rich plasma

ASJC Scopus subject areas

  • Urology
  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

The Neuroprotective Effect of Platelet-rich Plasma on Erectile Function in Bilateral Cavernous Nerve Injury Rat Model. / Wu, Chien Chih; Wu, Yi No; Ho, Hsiu O.; Chen, Kuo Chiang; Sheu, Ming Thau; Chiang, Han-Sun.

In: Journal of Sexual Medicine, Vol. 9, No. 11, 11.2012, p. 2838-2848.

Research output: Contribution to journalArticle

@article{7486df5eaf8749bb844d643630e5f1b0,
title = "The Neuroprotective Effect of Platelet-rich Plasma on Erectile Function in Bilateral Cavernous Nerve Injury Rat Model",
abstract = "Introduction. Neurogenic erectile dysfunction resulting from cavernous nerve (CN) injury is a major complication caused by radical prostatectomy. The use of platelet-rich plasma (PRP) on the nerve-injured site has shown promising results for the nerve regeneration. However, the effects of PRP injection in corpus cavernosum after bilateral CN injury have never been investigated. Aim. To assess the neuroprotective effect of PRP injection in corpus cavernosum after bilateral CN injury. Methods. Male Sprague-Dawley rats were randomly divided into three groups: Group I underwent sham operation, while the remaining two groups underwent bilateral CN crush. Crush injury groups were treated at the time of injury with an application of PRP or normal saline only injection in the corpus cavernosum, respectively. Four weeks later, erectile function (EF) was assessed by CN electrosimulation, and CNs as well as penile tissue were collected for histology. Main Outcome Measures. Intracavernous pressure (ICP) monitored during electrical stimulation of CNs; myelinated axons number of CNs and dorsal penile nerve; collagen type change, number of apoptotic cells, and mRNA expression of caspase-3 and transforming growth factor-β1 (TGF-β1) in the corpus cavernosum. Results. Four weeks after surgery, in the vehicle-only group, the functional evaluation showed a lower mean maximal ICP than that in the sham group (P",
keywords = "Cavernous nerve, Growth factor, Neurogenic erectile dysfunction, Neuroprotective, Platelet-rich plasma",
author = "Wu, {Chien Chih} and Wu, {Yi No} and Ho, {Hsiu O.} and Chen, {Kuo Chiang} and Sheu, {Ming Thau} and Han-Sun Chiang",
year = "2012",
month = "11",
doi = "10.1111/j.1743-6109.2012.02881.x",
language = "English",
volume = "9",
pages = "2838--2848",
journal = "Journal of Sexual Medicine",
issn = "1743-6095",
publisher = "Blackwell Publishing Ltd",
number = "11",

}

TY - JOUR

T1 - The Neuroprotective Effect of Platelet-rich Plasma on Erectile Function in Bilateral Cavernous Nerve Injury Rat Model

AU - Wu, Chien Chih

AU - Wu, Yi No

AU - Ho, Hsiu O.

AU - Chen, Kuo Chiang

AU - Sheu, Ming Thau

AU - Chiang, Han-Sun

PY - 2012/11

Y1 - 2012/11

N2 - Introduction. Neurogenic erectile dysfunction resulting from cavernous nerve (CN) injury is a major complication caused by radical prostatectomy. The use of platelet-rich plasma (PRP) on the nerve-injured site has shown promising results for the nerve regeneration. However, the effects of PRP injection in corpus cavernosum after bilateral CN injury have never been investigated. Aim. To assess the neuroprotective effect of PRP injection in corpus cavernosum after bilateral CN injury. Methods. Male Sprague-Dawley rats were randomly divided into three groups: Group I underwent sham operation, while the remaining two groups underwent bilateral CN crush. Crush injury groups were treated at the time of injury with an application of PRP or normal saline only injection in the corpus cavernosum, respectively. Four weeks later, erectile function (EF) was assessed by CN electrosimulation, and CNs as well as penile tissue were collected for histology. Main Outcome Measures. Intracavernous pressure (ICP) monitored during electrical stimulation of CNs; myelinated axons number of CNs and dorsal penile nerve; collagen type change, number of apoptotic cells, and mRNA expression of caspase-3 and transforming growth factor-β1 (TGF-β1) in the corpus cavernosum. Results. Four weeks after surgery, in the vehicle-only group, the functional evaluation showed a lower mean maximal ICP than that in the sham group (P

AB - Introduction. Neurogenic erectile dysfunction resulting from cavernous nerve (CN) injury is a major complication caused by radical prostatectomy. The use of platelet-rich plasma (PRP) on the nerve-injured site has shown promising results for the nerve regeneration. However, the effects of PRP injection in corpus cavernosum after bilateral CN injury have never been investigated. Aim. To assess the neuroprotective effect of PRP injection in corpus cavernosum after bilateral CN injury. Methods. Male Sprague-Dawley rats were randomly divided into three groups: Group I underwent sham operation, while the remaining two groups underwent bilateral CN crush. Crush injury groups were treated at the time of injury with an application of PRP or normal saline only injection in the corpus cavernosum, respectively. Four weeks later, erectile function (EF) was assessed by CN electrosimulation, and CNs as well as penile tissue were collected for histology. Main Outcome Measures. Intracavernous pressure (ICP) monitored during electrical stimulation of CNs; myelinated axons number of CNs and dorsal penile nerve; collagen type change, number of apoptotic cells, and mRNA expression of caspase-3 and transforming growth factor-β1 (TGF-β1) in the corpus cavernosum. Results. Four weeks after surgery, in the vehicle-only group, the functional evaluation showed a lower mean maximal ICP than that in the sham group (P

KW - Cavernous nerve

KW - Growth factor

KW - Neurogenic erectile dysfunction

KW - Neuroprotective

KW - Platelet-rich plasma

UR - http://www.scopus.com/inward/record.url?scp=84868199806&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868199806&partnerID=8YFLogxK

U2 - 10.1111/j.1743-6109.2012.02881.x

DO - 10.1111/j.1743-6109.2012.02881.x

M3 - Article

C2 - 22906160

AN - SCOPUS:84868199806

VL - 9

SP - 2838

EP - 2848

JO - Journal of Sexual Medicine

JF - Journal of Sexual Medicine

SN - 1743-6095

IS - 11

ER -